Resultados de la búsqueda 21-30 of 14530 for Severe hypokalaemia

  1. Cirugía - Ensayos clínicos - Mayo Clinic

    STAR Trial (Siegel Transcatheter Aortic Valve Replacement In Patients With Symptomatic Severe Aortic Stenosis). Jacksonville, Fla., Rochester, Minn. To ...

  2. Bajo nivel de potasio o hipopotasemia - Causas y definición - Mayo Clinic

    ... hypokalemia?query=Hypokalemia. Accessed Feb. 28, 2025. Mount DB, et al. Causes of hypokalemia in adults. https://www.uptodate.com/contents/search. Accessed ...

  3. Médicos y departamentos

    Reeder GS, et al. Diagnosis of acute myocardial infarction. https://www.uptodate.com/contents/search. Accessed Dec. 29, 2025. What is a heart ...

  4. Hematología - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  5. Hematología - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  6. Hematología - Ensayos clínicos - Mayo Clinic

    Giving inotuzumab ozogamicin with chemotherapy may work better in treating young adults with B acute lymphoblastic leukemia. The Impact of a Geriatric ...

  7. Hematología - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

  8. Cirugía - Ensayos clínicos - Mayo Clinic

    Patients with POAF tend to have worse acute and long-term clinical outcomes. BoxX-NoAF is a randomized trial to evaluate if prophylactic ablation and exclusion ...

  9. Médicos y departamentos

    Reeder GS, et al. Diagnosis of acute myocardial infarction. https://www.uptodate.com/contents/search. Accessed Dec. 29, 2025. What is a heart ...

  10. Hematología - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...